IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
See all recalls from IMBRUVICA →Recalled Product
IMBRUVICA (ibrutinib), 140 mg, 280 mg, 420 mg and 560 mg tablets, and 140 mg capsules
✅ What Should You Do?
- ⚠️ Stop using this product until you have checked the recall details below.
- Follow the instructions from the issuing agency (see below).
- 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
- 📋 Report a product safety incident to Health Canada
Looking for a safe alternative?
Search Amazon Canada for IMBRUVICA (ibrutinib), 140 mg, →
Hazard / Issue
New safety information - Product safety
Issued by
Marketed health products
⚖️ Were You Affected?
If you were injured or suffered a loss due to this recalled product, you may have legal options.
Search for Class Action Lawyers →Consumer Recalls Canada is not a law firm and does not provide legal advice. We may receive a referral fee if you inquire. We are not affiliated with any law firm or legal service.
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime